What is Repligen's preferred stock?

Repligen (RGEN) reported preferred stock of $0 in Q1 2026.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

Repligen RGEN Preferred Stock

Preferred Stock at other companies

RevvityRVTY

$0—

Agilent TechnologiesA

$0—

Bio-Rad LaboratoriesBIO

$0—

Charles River LaboratoriesCRL

$0—

WAT

Waters CorporationWAT

$0—

EntegrisENTG

$0—

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's preferred stock?: Repligen (RGEN) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.